J&J, AstraZeneca Explore Covid-19 Vaccine Modification

Johnson & Johnson, JNJ -0.16% AstraZeneca PLC AZN 1.46% and the University of Oxford, along with outside scientists, are conducting early-stage research into whether potential modifications of their Covid-19 vaccines could reduce or eliminate the risk of rare but serious blood clots